TTM Technologies Rides Record Growth in Earnings Call

Ttm Technologies ((TTMI)) has held its Q1 earnings call. Read on for the main highlights of the call.

TTM Technologies’ latest earnings call struck an upbeat tone as management highlighted surging revenue, expanding margins, and a swelling backlog that signal strong demand across core markets. While executives acknowledged higher capital spending, negative free cash flow, and some FX and auto-market headwinds, they framed these as manageable trade-offs to capture structural growth.

Record Revenue Sets a New Benchmark

TTM reported Q1 fiscal 2026 net sales of $846.0 million, a 30% year-over-year increase and the highest quarterly revenue in the company’s history. Management emphasized that this performance reflects both strong end-market demand and favorable product mix, laying a solid base for further growth this year.

EPS Surges on Profitability Gains

Non-GAAP earnings per share climbed to $0.75, up 50% from a year earlier, underscoring powerful operating leverage as volumes scale. GAAP net income also improved to $50.0 million, or $0.47 per share, versus $32.2 million, or $0.31, highlighting broad-based profit expansion beyond adjusted metrics.

Adjusted EBITDA and Margins Move Higher

Adjusted EBITDA rose to $132.9 million, up roughly 33.6% year over year, with margins edging up to 15.7% from 15.3%. The call stressed that this improvement came despite growth investments, suggesting the company is scaling efficiently as demand accelerates.

Gross and Operating Margins Expand Sharply

Gross margin expanded to 22.3%, a 150-basis-point improvement from 20.8% in the prior-year quarter, driven by mix and operational efficiencies. Operating margin climbed even more, reaching 12.8%, up 230 basis points from 10.5%, reflecting cost discipline and better factory performance.

Data Center, Medical, and Defense Drive Demand

End-market trends were a highlight, with data center and networking sales jumping 61% year over year and accounting for 36% of Q1 sales, expected to reach about 42% in Q2. Medical, industrial, and instrumentation revenue also rose 61% and made up 16% of sales, while aerospace and defense grew 11% and represented a sizable 40% share.

Bookings and Backlog Underscore Growth Momentum

The company’s 90-day backlog swelled to $787 million, up from $517 million a year ago, an increase of roughly 52% that enhances near-term visibility. Overall book-to-bill stood at about 1.41, with commercial orders particularly strong at 1.65 and aerospace and defense at a healthy 1.10.

Penang Facility Ramps Improve Profit Outlook

Management highlighted notable yield improvements at the Penang facility, rising from roughly 40% previously to about 70–80%, a key operational milestone. Executives indicated that this site is approaching breakeven later in fiscal 2026, positioning it to become a positive contributor as volumes build.

Cash Flow Drag from Growth and CapEx

Despite robust earnings, free cash flow was a usage of $85.0 million in Q1, slightly worse than the $74.0 million outflow a year ago, as working capital rose to support growth. Operating cash flow improved to $21.7 million, but elevated inventory and receivables tied to strong demand weighed on overall cash generation.

CapEx Accelerates to Support Capacity

Capital expenditures reached $107 million in the quarter, reflecting aggressive investment in capacity and technology. Full-year 2026 CapEx guidance was raised to $300–$320 million, up from the prior $240–$260 million range, signaling management’s conviction in long-term demand despite near-term cash pressure.

FX Losses Temper Bottom Line

Non-operating items turned into a drag, with realized foreign exchange and related items totaling a net expense of $6.8 million versus income of $1.5 million a year ago. The company cited a $7.0 million FX loss driven by a weakening U.S. dollar, a reminder that currency swings remain a risk factor even in a strong fundamental environment.

Automotive Weakness Kept in Check

Automotive sales modestly declined and now account for about 8% of overall revenue, reflecting softer conditions in that end market. Management noted that the downturn was less severe than feared and emphasized a selective approach to automotive exposure, focusing resources on more attractive, higher-growth verticals.

Supply Chain and Backlog Risks in Focus

Executives flagged industry-wide supply-chain pressures, including longer lead times and potential laminate and material cost exposure tied to commodities, even though oil-linked laminate inflation has not yet become material. They also reminded investors that the enlarged 90-day backlog is subject to cancellations, highlighting some execution and visibility risk amid rapid growth.

Guidance Signals Confidence in Sustained Growth

For Q2 fiscal 2026, TTM guided net sales between $930 million and $970 million and non-GAAP EPS of $0.82 to $0.88, implying continued top- and bottom-line expansion. Management expects the first-half growth trajectory to carry into the second half, while planning SG&A around 7.4% of sales, R&D near 1%, and maintaining elevated CapEx of $300–$320 million for the year to accelerate capacity expansion.

TTM’s call painted a picture of a company leaning into a powerful growth cycle, with record revenue, improving margins, and a swelling backlog overshadowing near-term cash and FX headwinds. For investors, the story is one of strong demand in data center, medical, and defense, backed by confident guidance and heavy investment aimed at turning today’s challenges into tomorrow’s earnings power.